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ABSTRACT 
In essential hypertension, mainly Vata prakopa occurs, particularly Vyana vata as it is responsible 
for Rasa- rakta samvahana. By virtue of its Ruksha, Sheeta and Khara guna, Rasa-rakta vahini 
dhamanis are constricted, also its Ruksha guna dries the Malarupa kapha at the inner side of the 
vessels making them more rigid (Kathin). Vascular lumen may be reduced further leading to 
obstruction in it. So, for normal circulatory function, increased force of Vyana vayu is required 
resulting into Vyana bala Vaishamya and hence leading to the development of hypertension. The 
WHO rates hypertension as one of the most important causes of premature death worldwide. 
Worldwide, approximately 1 billion people have hypertension, contributing to more than 7.1 
million deaths per year. The number of adults with hypertension in 2025 is predicted to increase by 
about 60% to a total of around 1.56 billion. In India, Cardiovascular diseases caused 2.3 million 
deaths in the year 1990; this is projected to double by the year 2020. Numbers of drugs are 
available in modern medicine to treat the disease in its symptomatically active state but still are 
unable to cure the hypertension. Hyper function of Vyana is considered under Vyana Bala 
Vaishamya which produces increased force in the wall of the channels (blood vessels) to produce 
the disease hypertension. In the present clinical trial ‘Punarnava Churna’ is orally administered for 
1 month twice a day after food. 30 clinically diagnosed patients of hypertension were randomly 
selected and divided into two groups. BP, CBC, RBS, ECG, Blood urea, Serum creatinine and Lipid 
profile were done before and after the clinical trial. After completion of study signs and symptoms 
were controlled significantly and also there were significant changes in laboratory findings. 
KEYWORDS: Hypertension, Rasa- rakta samvahana, Vyana Bala Vaishamya, Vyana, Punarnava 
Churna. 
INTRODUCTION 
Hypertension (HTN or HT), also known as 
high blood pressure or arterial hypertension, is a 
chronic medical condition in which the blood 
pressure in the arteries is persistently elevated.[1] 
Hypertension is common disorder rising in incidence 
and once established treatment is obligatory. It is 
growing in incidence globally particularly in 
developing countries.[2] The WHO rates HTN as one of 
the most important causes of premature death 
worldwide.[3] 
 Overall, approximately 20% of the world’s 
adults are estimated to have hypertension, when 
hypertension is defined as BP in excess of 140/90mm 
Hg. The number of adults with hypertension in 2025 
is predicted to increase by about 60% to a total of 
around 1.56 billion. In India, Cardiovascular diseases 
caused 2.3 million deaths in the year 1990; this is 
projected to double by the year 2020. Hypertension 
is directly responsible for 57% of all stroke deaths 
and 24% of all coronary heart disease deaths in India.  
Vyana is a type of Vata which moves all over 
the body. Its Nirukti indicates that it affects the whole 
body. Bala here is an indicative of the normal Guna 
(properties) and Karma (functions) of Vyana. 
Vaishamya refers to Vikriti or disequilibrium of dosha 
in which they are able to produce the disease. As per 
(Ch. Sha. 6/4,) Vaishamya means Vrddhi or Hrasa, i.e., 
either increase or decrease. Therefore, Vyana Bala 
Vaishamya may either be considered as increased or 
decreased function of Vyana. But, it is also mentioned 
that the decreased Dosha is not able to manifest its 
own symptoms.[4] So, the decreased Dosha may not 
be able to produce any disease. Hence, in the present 
study, hyper-function of Vyana Vata is considered 
under Vyana Bala Vaishamya which produces 
increased force in the wall of the channels (blood 
vessels) to produce the disease ‘Hypertension’. 
In essential hypertension, mainly Vata-
prakopa occurs, particularly Vyana Vata as it is 
responsible for Rasarakta sanvahana. By virtue of its 
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Ruksha, Sheeta and Khara Chala, Rasa-raktavahini 
dhamanis are constricted, also its Ruksha Chala dries 
the Mala rupa kapha at the inner side of the vessels 
making them more rigid (Kathin). Vascular lumen 
may be reduced further leading to obstruction in it. 
So, for normal circulatory function, there is increased 
force of Vyana. Vyana is required resulting into Vyana 
Bala Vaishamya and hence leading to the 
development of hypertension. 
The assessment of effects of Punarnava 
Churna in the patients of hypertension was the chief 
objective of the study along with the replacement of 
the modern anti- hypertensive drugs by a safe and 
effective alternative in Ayurveda. 
AIMS AND OBJECTIVES  
To conduct an Upashyatmaka (randomized trial) to 
assess the efficacy of Punarnava Churna (Boerhavia 
diffusa) on Vyana Bala Vaishmya (Hypertension). 
MATERIALS AND METHODS 
Study site: Laboratory / OPD / IPD of NIA hospitals, 
Jaipur and certain NIA camp sites.  
Selection of patients 
For the clinical study, 30 subjects of 
hypertension clinically diagnosed and randomly 
selected from the OPD/IPD of N.I.A, Jaipur, after 
excluding the drop outs and cases that did not fulfill 
the criteria of diagnosis. Subjects were given drug 
Punarnava Churna (Boerhavia diffusa) daily for 30 
days in the dose of 2gms twice a day. After complete 
the trial, results before treatment and after treatment 
were compared and analyzed statistically. 
Inclusion Criteria 
1] Patients willing to sign the consent form for the 
clinical trial. 
2] Either sex or age group above 18 yrs. 
3] Patients of Hypertension (JNC 8th Criteria.) 
Exclusion Criteria 
1] Known case of Renal diseases, Diabetic Mellitus 
2] Pregnancy induced hypertension 
3] History of drugs like Oral Contraceptive Pills, 
steroids.  
4] Known case of Ventricular hypertrophy, Secondary 
hypertension, hypertension with severe 
complication. 
5] Known case of Portal hypertension 
6] Renal artery stenosis induced hypertension. 
Diagnostic Criteria 
 History, clinical examination, systemic 
examination according to specially prepared CRF 
incorporating Ayurveda parameters of Dashvidha 
pariksha and all the signs and symptoms of disease 
etc.  
 Laboratory parameters- BP, CBC, RBS, ECG, Blood 
urea, Serum creatinine and Lipid profile. 
Plan of the Study  
The present trial was randomized. 30 
subjects of hypertension were clinically diagnosed. 
They were treated with drug Punarnava Churna 
(Boerhavia diffusa) daily for 30 days in the dose of 
2gms twice a day. At the end of the treatment, 
efficacy of the drug was statistically analyzed.  
Assessment of Disease 
Assessment of the blood pressure was done 
by measuring it with the help of its measuring device, 
sphygmomanometer and was observed after each 
follow up for its measurement. The relative extent of 
all these criteria was recorded according to the rating 
scale in each patient at the initial stage and 
subsequent follow-ups. 
Data Documentation and Statistical Analysis  
Data collected in various stages of the clinical 
trial were analyzed using Graph Pad Instat (version 
3.10, 32 bit for windows created July 10, 2009).  
Parameters of assessment of symptoms 
(1) Severity scoring of Sirahshula (headache) 
0 = No headache. 
1 = Occurs rarely, relieves without medications. 
2 = Occurs only when subjected to stress and 
exertion.  
3 =frequently present and relieves with medications 
but not interfering with daily activities.  
4 =Persistent headache, not cure even on 
medications, also interfering with daily activities.  
(2) Severity scoring of Hritdrava (Palpitation) 
0 = No palpitation  
1 = Palpitation caused by vigorous physical exercise. 
2 = Caused by moderate physical exercise. 
3 = on daily routine work. 
4 = Even at rest also. 
(3) Severity scoring of Bhrama (Dizziness) 
0 = Not present at all. 
1 = rarely present.  
 2 = occasionally present but only on movement. 
3 = frequently present for some moment even in 
sitting condition. 
 4 = Present even on lying condition and patient is 
unable to hold himself without any support. 
(4) Severity scoring of Klama (Easy fatigability) 
0 = Never  
1 = after heavy physical work. 
2 = after moderate physical work. 
3 = Easy fatigability even on daily routine work. 
4 = Even on rest. 
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(5) Severity scoring of Anidra 
(Insomnia/disturbed sleep) 
0 = Sound sleep.  
1 = occasionally awakenings at night. 
2 = Disturbed sleep, wake up 1-2 times at night. 
3 = Very less sleep in small intervals making patient 
irritable.  
4 = Not getting sleep without medicine.  
(6) Severity scoring of Raktang akshita (Redness 
of eyes)  
0 = Nil  
1 = rarely and mild redness remains only for small 
duration. 
2 = frequently and mild / moderate redness remains 
for 2 -3 hrs.  
3 = Often and moderate / severe redness remains for 
longer duration. 
4 = Continuous and moderate / severe redness nearly 
always present. 
(7) Severity scoring of Krodha prachurata (Loss of 
patience)  
0 = Normal. 
1 = rarely angry by major provocation and for very 
short duration. 
2 = rarely angry by moderate to major provocation 
for long duration. 
3 = Often angry by mild to major provocation for 
short duration.  
4 = Continuous angry and irritable.  
(8) Severity scoring of Swasakritchata 
(Dyspnoea) 
0 = Absent.  
1= Present on severe exertion 
2 = Present on moderate exertion 
3 = Present on mild exertion 
4 = Present even on rest 
(9) Severity scoring of Bahumutrata (Polyuria)  
0 = Absent.  
1 = occasionally present 
2 = Present only in daytime 
3 = Persistent but not associated with undue thirst 
4 = Persistent and associated with undue thirst  
(10) Severity scoring of Smritinash (Impaired 
memory) 0 = Absent.  
1 = Rarely Present.  
2 = occasionally present for a short time but reminds 
it sooner.  
3 = frequently present for a long time but reminds it 
later on.  
4 = persistently present and doesn’t remind later 
also.  
(11) Severity scoring of Kampa (Tremors) 
0 = Absent.  
1 = rarely present only on some vigorous physical 
exercise.  
2 = Present on slight physical or mental exertion.  
3 = Present even on doing daily routine work and 
with mild exertion.  
4 = at rest also. 
(12) Severity scoring of Daurbalya (Weakness) 
0 = Absent. 
1 = occasionally present.  
2 = frequently present but only for some short 
duration.  
3 = Always present but not interfering with daily 
activities.  
 4 = Always present interfering with daily. 
Assessment of results 
 Assessment Criteria for effect of treatment on 
blood pressure 
To calculate the percentage relief in blood pressure, 
mean BP of patients of both the times, i.e. before 
treatment and after treatment, of each group was 
observed and percentage relief was calculated at the 
end by using the below given formula;  
Percentage relief in Systolic Blood Pressure =  
Mean of BP (BT) - Mean of BP (AT) x 100 
Mean of BP (BT) 
Percentage relief in Diastolic Blood Pressure =  
Mean of BP (BT) - Mean of BP (AT) x 100 
Mean of BP (BT) 
Trial Drugs 
Table 1: Rasa panchak of Punarnava[5] 
Drug Botanical name Rasa Guna Virya Vipaka Doshakarma 
Punarnava Boerhavia diffusa Madhura, Tikta, 
Kashaya 
Laghu, 
Ruksha 
Ushna Madhura Vatashlaishmahara 
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OBSERVATION 
Table 2: For subjective (non-parametric) variables 
S.No. Symptoms Mean (n=30) % 
Change 
S.D. 
(±) 
S.E 
(±) 
‘p’ 
Value 
Result 
B.T. A.T. Diff. 
1. Sirahshula 2.53 1.10 1.43 56.58 0.77 0.14 0.0012 VS 
2. Hritdrava 2.77 1.33 1.43 51.81 0.82 0.15 < 0.0001 VS 
3. Bhrama 2.13 1.53 0.60 28.13 0.89 0.16 < 0.0001 VS 
4. Klama 2.30 2.43 -0.13 -5.80 1.89 0.34 0.1390 NS 
5. Anidra 2.47 1.20 1.27 51.35 1.01 0.19 <0.001 VS 
6. Raktangakshita 5.01 4.99 0.02 0.40 1.68 0.31 0.0416 S 
7. Krodhaprachuryata 2.47 1.00 1.47 59.46 0.73 0.13 <0.0001 VS 
8. Svashkrichhata 2.33 1.03 1.30 55.71 0.84 0.15 <0.0001 VS 
9. Bahumutrata 2.20 1.10 1.10 50.00 0.76 0.14 <0.0001 VS 
10. Smratinash 5.11 4.23 0.89 17.34 0.92 0.17 <0.0001 VS 
11. Kampa 5.35 4.36 0.99 18.45 0.94 0.17 <0.001 VS 
12. Daurbalya 2.73 1.57 1.17 42.68 0.79 0.14 <0.001 VS 
Wilcoxon Matched Pair Signed Rank Test in individual group comparing before and after scores.  
Table 3: For objective (parametric) variables 
S.No.  
Symptoms 
Mean (n=30) % 
Change 
S.D. 
(±) 
S.E 
(±) 
‘t’ 
value 
‘p’ 
Value 
Result 
B.T. A.T. Diff. 
1. Pulse 80.07 79.37 0.70 0.87 5.07 0.92 0.76 0.4989 NS 
2. B.P.(systolic) 142.67 131.87 10.80 7.57 11.60 2.12 5.10 <0.0001 VS 
3. B.P.(diastolic) 91.40 85.60 5.80 6.35 6.29 1.15 5.05 <0.0001 VS 
4. RBS 115.13 114.97 0.17 0.14 20.37 3.72 0.04 0.1272 NS 
5. TLC 6630.33 6563.33 67.00 1.01 272.58 49.77 1.35 0.1927 NS 
6. Blood urea 39.93 39.10 0.83 2.09 5.55 1.01 0.82 0.4178 NS 
7. Sr.creatinine 1.97 1.94 0.03 1.52 0.21 0.04 0.78 0.4445 NS 
8. Sr.cholesterol 208.73 204.90 3.83 1.84 16.92 3.09 1.24 0.1372 NS 
9. Sr.triglyceride 167.78 166.56 1.22 0.73 20.28 3.70 0.33 0.5804 NS 
10. HDL 85.28 84.29 0.99 1.16 4.98 0.91 1.08 0.0540 NS 
11. LDL 92.70 91.50 1.20 1.29 4.08 0.74 1.61 0.0101 S 
12. VLDL 33.45 33.29 0.15 0.46 2.75 0.50 0.31 0.0771 NS 
Paired t test (P = Two tailed ‘p’ value) - in individual group comparing before and after measurements  
Discussion on Effect of Treatments  
on Chief Complaints 
 Punarnava Churna showed better 
improvement in Krodhaprachuryata (59.46%), 
Daurbalya (42.68%), Anidra (51.35%), Hritdrava 
(51.81%), Svashkrichhata (55.71%), and Bahu-
mutrata (50%). They all showed statistically 
extremely significant result. Since, the trial drug is 
having Madhur rasa properties, so significant result 
has been found in the above said complaints. 
 It was found that Punarnava Churna had 
better results on Daurbalya, Anidra, Hritdrava, 
Svashkrichchhata, Bahumutrata and Krodha 
Prachurata.  
Probable Modes of Action of ‘Punarnava’ on 
Symptoms produce in Hypertension 
 It might have relieved the symptom Shirshula 
which is found most commonly in hypertension due 
to its Shirshula and Madhura, Tikta Rasa property 
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Shirshula and hypertension both have Pittadosha as 
dominant Dushya as Punarnava is said to be 
Madhura, Tikta rasa property (Pittshamaka). Same 
might be the reason of its effect on Raktangakshita as 
Pitta is predominantly involved in these features. It 
might have relieved in Kampa due to its property of 
Vataprashamana. 
The trial drug possess Rasayana property by 
which it helps in relieving stress, anxiety giving 
stability to mind which might be the reason of getting 
relief by it in Anidra and Krodhprachuryta. Being a 
Rasayana, it might have improved in Smritinash. 
Madhura Rasa of drug causes Pittashamak. Madhura 
rasa by its Prahladana guna increases the Oja in the 
body and thus regulates the circulatory function of 
heart by reducing Chala guna of Vata. The drug also 
possesses the property of Mutral and Balya, that’s 
why it might have relieved in the symptoms 
Hritdrava and Svashkrichhata. The drug is having 
Deepan property which helps to alleviate obstruction 
in the Srotas due to Aam by its digestion and thereby 
resulting into Srotoshodhana and Vatanulomana. This 
might have the reason of its relief in Klama. 
It is also having the property of Balya and it is 
also said to be used in Daurbalya as its Rogaghnata. 
That is why it must have helped in getting relief in 
Daurbalya. Rasayana drugs also possess the property 
of Srotoshodhana which makes them useful where the 
Samprapti of disease is due to Avarana i.e., due to 
Margavrodha, as the same happens in hypertension. 
Discussion Regarding Effect of Therapy on Blood 
Pressure 
 Systolic Blood Pressure- In the study, an average 
of 7.57% decrease was noticed, respectively which 
was considered statistically extremely significant in 
the cases.  
 Diastolic Blood Pressure- In the study, an average 
of 6.35% decrease was noticed, respectively which 
was considered statistically extremely significant in 
the cases.   
Probable Modes of Action of Drug ‘Punarnava’ on 
the Blood Pressure 
The drug is having Deepan property which 
helps to alleviate obstruction in the Srotas due to 
Aam by its digestion and thereby resulting into 
Srotoshodhana and Vatanulomana. Destruction of 
Srotorodha regulates the movements of Vata in its 
normal direction through the micro channels. Thus, 
the drug may be effective where pathogenesis of the 
disease involves obstruction i.e., vitiation of Vata due 
to its Margavrodha, which also applies on 
hypertension. Hence the trial drug having Ushna 
virya, it mainly acts on vitiated Vata dosha and 
thereby also helps to alleviate the Samprapti of 
disease. The drug also helps in the breaking of etio-
pathogenesis of the disease at the level of Tridosha by 
its property of Tridoshhara as in essential 
hypertension. The drug might have reduced the blood 
volume resulting into decreased blood pressure due 
to its Mutral property. Tikta rasa may act on 
Rasavaha, Raktavaha and Medovaha Srotas by its 
Shothahara, Deepan, Pachan property. It absorbs 
excess Kleda, Sweda, Kapha, Pitta in the body by its 
Pachan property and helps in reducing blood volume. 
Hence, we can say that the significant result 
produced by Punarnava Churna in Vyana Bala 
Vaishamya i.e., hypertension may be due to its Balya 
effect thereby producing anxiolytic, antistress, CNS 
depressant effect by inhibiting noradrenergic 
sympathetic nerves supplying to the heart. Through 
its Pachan, Mutral, Vatanulomana properties, it 
relieved Srotorodha and does digestion of Aam and 
also decreases blood volume which it may have 
contributed to decrease in blood pressure. 
Discussion on Effect of Treatments on the Lab 
Investigations 
(1) Random Blood Sugar- In the study, an average 
of 0.14% decrease was noticed, respectively which 
was considered statistically not significant in the 
cases.  
(2) Blood urea- In the study, an average of 2.09% 
decrease was observed, respectively which was 
considered statistically not significant in both the 
cases.  
(3) Serum Creatinine- In the study, an average of 
1.52% decrease was observed, respectively which 
was considered statistically not significant in the 
cases.  
(4) Serum Cholesterol- In the study, an average of 
1.84% decrease was observed, respectively which 
was considered statistically extremely significant in 
the cases.  
(5) Serum Triglycerides- In the study, an average of 
0.73% decrease was observed, respectively which 
was considered statistically not significant.  
(6) HDL- In the study, an average of 1.16% decrease 
was observed, respectively which was considered 
statistically very significant.  
(7) LD- In the study, an average of 1.29% decrease 
was observed, respectively which was considered 
statistically not significant in the cases.  
(8) VLDL- In the study, an average of 0.46% decrease 
was observed, respectively which was considered 
statistically not significant in the cases.  
(9) TLC- In the study, an average of 1.01% decrease 
was observed, respectively which was considered 
statistically significant. 
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CONCLUSION 
1. Punarnava Churna showed statistically extremely 
significant results in various sign and symptoms 
of Vyana Bala Vaishamya. 
2. In Punarnava Churna showed statistically highly 
significant results in Bahumutrata, Krodha 
pracuryata, Klama, Bhram. It showed statistically 
significant result in LDL but statistically non 
significant results in blood urea, HDL. 
3. From the results obtained Punarnava Churna, it 
can be concluded that therapy Punarnava Churna 
is a safe and effective Ayurvedic treatment of 
Vyana Bala Vaishamya (Hypertension).  
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